SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-062681
Filing Date
2023-05-19
Accepted
2023-05-19 16:05:50
Documents
12
Period of Report
2023-05-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316254d1_8k.htm   iXBRL 8-K 45488
  Complete submission text file 0001104659-23-062681.txt   220408

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coll-20230518.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20230518_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20230518_pre.xml EX-101.PRE 22609
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2316254d1_8k_htm.xml XML 3622
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 23940027
SIC: 2834 Pharmaceutical Preparations